Press release
Discover the Growth of the Polycystic Ovarian Syndrome (PCOS) Therapeutics Market
Polycystic ovarian syndrome (PCOS) is an endocrine disorder observed in females during their reproductive age, due to which they may suffer from infertility problems. PCOS is characterized by a range of symptoms such as acne, menstrual irregularities, hirsutism, obesity, insulin resistance, anovulation and infertility. PCOS therapeutics include a wide a range of medications that are available in the worldwide. The global market for PCOS therapeutics can be segmented into six major categories, namely, anti-androgen drugs, contraceptive drugs, ovulation stimulants, cancer treatment drugs,diabetes treatment drugs and dietary supplements.Obtain Report Details @ http://www.transparencymarketresearch.com/pcos-therapeutics-market.html
Major driving factors for the growth of the PCOS therapeutics market include, increasing prevalence of diabetes, rising obesity rates and increasing genetic and hormonal disorders worldwide. Diabetic and obese females are more prone to polycystic ovarian syndrome, and their rising levels will lead to more PCOS females, hence will create a demand for PCOS therapeutics worldwide.
Presence of large number of off-label and generic drugs in this category may restrain the growth of this market. However, rising worldwide dissatisfaction from various off-label drugs that are available to treat PCOS will create more demand for branded drugs and thus help grow this market in future. A large number of drugs currently in clinical trials and expected to be commercialized in the near future will provide newer opportunities to this market.
Geographically, North America is the largest market for PCOS therapeutics followed by Europe. High prevalence and huge demand for diagnosis and treatments for PCOS in the region are major factors that largely contribute towards the growth of this market in these regions. Asia-Pacific market is expected to show the highest growth rate in PCOS therapeutics due to rising awareness about women healthcare and increasing affordability of the population.
Fill the Form to Gain Deeper Insights on this Market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1870
Major players operating in PCOS therapeutics market are AstraZeneca plc, Biocinese, Catalysis, S.L., Crinetics Pharmaceuticals, Inc., Eugonia, EffRx, Inc., Ferring Pharmaceuticals, Inc., Merck KGaA, Neurocrine Biosciences, Inc., Reliance Life Sciences Pvt. Ltd. and Shire plc.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Contact Us
Transparency Market Research
90 State Street, Suite 700,
Albany, NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Discover the Growth of the Polycystic Ovarian Syndrome (PCOS) Therapeutics Market here
News-ID: 716156 • Views: …
More Releases from Transparency Market Research
Medical Rehabilitation Services Market Poised for Robust Growth, Reaching USD 29 …
The global Medical Rehabilitation Services Market is entering a transformative growth phase, fueled by rapid adoption of tele-rehabilitation, increasing preference for personalized treatment plans, and strong government initiatives to improve access to rehabilitative care. According to the latest industry outlook, the market was valued at US$ 147.3 billion in 2023 and is projected to reach US$ 292.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 6.5%…
Metal Card Making Machine Market Expanding at 4.6% CAGR Through 2034 - By Machin …
The global Metal Card Making Machine Market was valued at US$ 578.7 Mn in 2023 and is projected to reach US$ 948.2 Mn by the end of 2034, growing at a compound annual growth rate (CAGR) of 4.6% during the forecast period 2024-2034. Steady growth in demand for premium, durable, and secure cards across banking, identification, membership, and luxury branding applications is driving sustained investments in advanced metal card manufacturing…
Medical Case Management Services Market 2034: Rising Chronic Care Needs to Push …
The global medical case management market is steadily gaining momentum as healthcare systems worldwide focus on improving patient outcomes, optimizing care coordination, and controlling escalating medical costs. In 2023, the market was valued at US$ 6.4 Bn. Supported by structural demographic shifts, expanding medical tourism, and rapid digitization of healthcare services, the market is projected to reach US$ 12.3 Bn by the end of 2034, growing at a compound annual…
Polymerase Chain Reaction (PCR) Market Set to Grow from US$ 10.1 Bn to US$ 24.0 …
The global Polymerase Chain Reaction (PCR) market represents one of the most critical and enduring segments of the life sciences and diagnostics industry. Valued at US$ 10.1 billion in 2024, the market is projected to reach US$ 24.0 billion by 2035, expanding at a compound annual growth rate (CAGR) of 8.2% from 2025 to 2035. This strong and sustained growth trajectory reflects the indispensable role of PCR technologies across clinical…
More Releases for PCOS
Polycystic Syndrome (PCOS) Market Expected to Reach USD 7.9 Billion by 2034
Polycystic Syndrome (PCOS) is a complex hormonal disorder affecting women of reproductive age, characterized by irregular menstrual cycles, excessive androgen levels, and polycystic ovaries. Beyond its reproductive implications, PCOS is closely linked to metabolic issues such as insulin resistance, obesity, and increased risk of type 2 diabetes and cardiovascular diseases.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70728
Over the past decade, growing awareness, improved diagnostic capabilities, and greater emphasis…
Empowering Women's Health: A New Era Dawns in the PCOS Therapeutics Market
Polycystic Ovarian Syndrome (PCOS) affects an estimated 8-13% of women of reproductive age worldwide, presenting a multifaceted challenge that spans hormonal imbalance, metabolic disruption, and reproductive health. Today, the PCOS therapeutics market stands at the forefront of medical innovation, as pharmaceutical companies, biotech startups, and academic researchers converge to address the unmet needs of millions of women. This industry outlines the latest trends, breakthrough therapies, and market dynamics shaping this…
Global Efforts to Address Polycystic Ovarian Syndrome (PCOS) Gain Momentum
The Polycystic Ovarian Syndrome (PCOS) Treatment Market is expected to grow from an estimated USD 3514.5 million in 2024 to USD 5546.3 million in 2033, at a CAGR of 5.20%. Global initiatives to raise awareness and address Polycystic Ovarian Syndrome (PCOS) are making significant strides in improving women's health. The World Health Organization (WHO) highlights PCOS as a critical health disorder due to its impact on reproductive health, metabolic well-being,…
Laser Hair Removal for PCOS: A Chicago Guide
Polycystic Ory Syndrome (PCOS) is a hormonal disorder that affects around 10% of women of reproductive age worldwide. PCOS leads to a range of symptoms like irregular menstrual cycles, insulin resistance, and more. The most challenging symptoms for many women with PCOS are excessive hair growth on their face, chest, and back. It's a condition known as hirsutism. Thanks to developments in laser hair removal Chicago https://vplaserhairremoval.com/laser-hair-removal-chicago-prices/ offers, individuals with…
Discover Optimal PCOS Fertility Health Today with Dr. Angela Potter
Learn the secrets to optimal PCOS fertility health and improve the chances of pregnancy
PORTLAND, OR - Polycystic ovarian syndrome (PCOS) is a condition often attributed to infertility, affecting more than five million women [https://www.endocrine.org/patient-engagement/endocrine-library/pcos] in the United States alone. Unfortunately, many women with PCOS are immediately pointed in the direction of in vitro fertilization (IVF) - a notoriously expensive procedure that does not guarantee a successful embryo transfer or pregnancy.…
PCOS Treatment Market Projected to Reach $6.84 Billion by 2034
According to a recent analysis by Fact.MR, the global (PCOS) treatments market is expected to experience significant growth in the coming years. This expansion is driven by several key factors: a rising incidence of PCOS, advancements in treatment methodologies, and a growing focus on women's health and wellness.
Get Free Sample Research Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=10043
PCOS is one of the most prevalent endocrine disorders among women of reproductive age globally. It manifests through symptoms…
